Policy / Regulatory

Shanghai Boosts Community Healthcare with Enhanced Reimbursement and Services

CompanyDeals

Novo Nordisk and Evotec Launch LAB eN² to Accelerate Drug Discovery for Rare Diseases

CompanyDeals

Roche Secures Global Rights to Ionis Pharmaceuticals’ Alzheimer’s and Huntington’s Disease Candidates

CompanyDrug

Takeda Receives FDA Approval for Subcutaneous Entyvio as UC Maintenance Therapy

CompanyMedical Device

Neusoft Medical’s NeuRT Aurora Receives NMPA Approval for Advanced Radiotherapy Platform

CompanyMedical Device

CStone Pharmaceuticals’ PDGFRA Mutation Detection Kit Receives NMPA Approval

CompanyDeals

RemeGen and Akeso Biopharma Initiate Phase II Study for Gastric Cancer Combo Therapy

CompanyDrug

Eli Lilly’s Insulin Biosimilar YouBiAn Approved for Diabetes Treatment in China

CompanyDrug

Everest Medicines’ Xerava Receives Marketing Approval from TFDA for cIAI Treatment

CompanyMedical Device

Sino Medical Sciences Receives Turkish Approval for HT Supreme Drug-Eluting Stent System

CompanyDrug

Konruns Pharmaceutical’s KC1036 Pediatric Indication Accepted for NMPA Review

CompanyDrug

Elpiscience Biopharmaceuticals Initiates Phase I Trial for Anti-LILRB2 Antibody ES009